A hospital system used at exceptional scale
In 2025, Renji handled 7.4584 million outpatient and emergency visits, 268,200 discharges and 134,000 inpatient surgeries.
When screening finds something, the specialist is already there
Renji combines China's No.1 gastroenterology department with four-campus tertiary care and same-hospital specialist routing.*
* Rankings and hospital figures are for reference and reconfirmed before booking.
Four campuses, one specialist network
Four Shanghai campuses connect 2,750 approved beds with 54 clinical and medical-technical departments.
Senior expertise across the system
Renji's workforce includes 776 senior experts, supported by extensive doctoral and master's teaching capacity.
Clinical strengths and research platforms
- Key specialties include Gastroenterology (national No.1), Rheumatology (national Top3), Neurology and Gynaecology/Reproductive Medicine; gastroenterology is the main fit for Health Screening GI endoscopy routing.
- Renji's official profile lists 13 national clinical key specialties, including gastroenterology, obstetrics, neurosurgery, general surgery, urology, nephrology, imaging, rheumatology, allergy, transplantation and critical care.
- State Key Laboratory for Oncology Systems Medicine and key laboratories in anaesthesia, gastroenterology and nephrology-related research.
- 835 national projects during the 14th Five-Year Plan period, including 779 National Natural Science Foundation projects.
Equipment and facilities
- Dual-source photon-counting CT, PET-CT, PET-MR, 320-row 640-slice CT and hybrid operating-room systems.
- Da Vinci robotic surgical system, TomoTherapy, linear accelerators and stereotactic X-ray radiotherapy systems.
- Remote medical teaching system and a 2,300m2 national-level clinical skills simulation centre.
- Health-management and specialist-routing capacity especially suited to Health Screening GI endoscopy, digestive follow-up, cardiovascular, imaging-heavy and internal-medicine pathways.
Selected specialists by department
Gastroenterology
Ma Xiong
Level II Professor, Chief Physician and Director of Gastroenterology. He completed postdoctoral research at Johns Hopkins University School of Medicine and is a member of the International Autoimmune Hepatitis Group and Global PBC Study Group.
Rheumatology
Ye Shuang
Chief Physician and Director of Rheumatology, specialising in severe inflammatory rheumatic disease. His clinical research has appeared in The New England Journal of Medicine and The Lancet family of journals.
Anaesthesiology
Xiao Jie
Chief Physician, master's supervisor and Deputy Director of Anaesthesiology. She was a visiting scholar at the University of Pennsylvania and is an American Heart Association Basic Life Support instructor trainer.
Urology
Pan Jiahua
Chief Physician, PhD supervisor and Director of Urology. He specialises in prostate cancer and has performed more than 2,000 da Vinci robotic procedures as primary surgeon.
Nuclear Medicine
Liu Jianjun
Professor, Chief Physician, PhD supervisor and Director of Nuclear Medicine. He specialises in PET/CT-based tumour diagnosis, staging and treatment-response assessment.